Back to Search Start Over

Short-term risk prediction after major lower limb amputation: PERCEIVE study

Authors :
Brenig L, Gwilym
Philip, Pallmann
Cherry-Ann, Waldron
Emma, Thomas-Jones
Sarah, Milosevic
Lucy, Brookes-Howell
Debbie, Harris
Ian, Massey
Jo, Burton
Phillippa, Stewart
Katie, Samuel
Sian, Jones
David, Cox
Annie, Clothier
Adrian, Edwards
Christopher P, Twine
David C, Bosanquet
S, French
Source :
British Journal of Surgery. 109:1300-1311
Publication Year :
2022
Publisher :
Oxford University Press (OUP), 2022.

Abstract

Background The accuracy with which healthcare professionals (HCPs) and risk prediction tools predict outcomes after major lower limb amputation (MLLA) is uncertain. The aim of this study was to evaluate the accuracy of predicting short-term (30 days after MLLA) mortality, morbidity, and revisional surgery. Methods The PERCEIVE (PrEdiction of Risk and Communication of outcomE following major lower limb amputation: a collaboratIVE) study was launched on 1 October 2020. It was an international multicentre study, including adults undergoing MLLA for complications of peripheral arterial disease and/or diabetes. Preoperative predictions of 30-day mortality, morbidity, and MLLA revision by surgeons and anaesthetists were recorded. Probabilities from relevant risk prediction tools were calculated. Evaluation of accuracy included measures of discrimination, calibration, and overall performance. Results Some 537 patients were included. HCPs had acceptable discrimination in predicting mortality (931 predictions; C-statistic 0.758) and MLLA revision (565 predictions; C-statistic 0.756), but were poor at predicting morbidity (980 predictions; C-statistic 0.616). They overpredicted the risk of all outcomes. All except three risk prediction tools had worse discrimination than HCPs for predicting mortality (C-statistics 0.789, 0.774, and 0.773); two of these significantly overestimated the risk compared with HCPs. SORT version 2 (the only tool incorporating HCP predictions) demonstrated better calibration and overall performance (Brier score 0.082) than HCPs. Tools predicting morbidity and MLLA revision had poor discrimination (C-statistics 0.520 and 0.679). Conclusion Clinicians predicted mortality and MLLA revision well, but predicted morbidity poorly. They overestimated the risk of mortality, morbidity, and MLLA revision. Most short-term risk prediction tools had poorer discrimination or calibration than HCPs. The best method of predicting mortality was a statistical tool that incorporated HCP estimation.

Details

ISSN :
13652168 and 00071323
Volume :
109
Database :
OpenAIRE
Journal :
British Journal of Surgery
Accession number :
edsair.doi.dedup.....9adad5921d34244b9d3c01c87bfde902
Full Text :
https://doi.org/10.1093/bjs/znac309